Neuzumab 150mg Injection Benefits & Uses
Neuzumab 150mg Injection is used to treat the following -
Main Benefits
Other Benefits
- Gastric Cancer
Neuzumab 150mg Injection Dosage & How to Take
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult(Female) |
|
| Geriatric |
|
| Adult |
|
Neuzumab 150mg Injection Related Warnings
-
Is the use of Neuzumab 150mg Injection safe for pregnant women?
Neuzumab can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Severe -
Is the use of Neuzumab 150mg Injection safe during breastfeeding?
Taking Neuzumab may lead to serious side effects if you are breastfeeding. Neuzumab should not be taken by breastfeeding women unless prescribed by the doctor.
Severe -
What is the effect of Neuzumab 150mg Injection on the Kidneys?
Neuzumab is not harmful for kidneys.
Safe -
What is the effect of Neuzumab 150mg Injection on the Liver?
Using Neuzumab does not have any harmful effects on the liver.
Safe -
What is the effect of Neuzumab 150mg Injection on the Heart?
You may experience side effects on your heart after taking Neuzumab. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
Moderate
Severe Interaction of Neuzumab 150mg Injection with Other Drugs
Neuzumab 150mg Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Neuzumab 150mg Injection Contraindications
If you are suffering from any of the following diseases, you should not take Neuzumab 150mg Injection unless your doctor advises you to do so -
- Angioedema
- Asthma
- COPD (Chronic Obstructive Pulmonary Disease)
- Pneumonitis
- Heart Disease
- Gastritis
- Pneumonia
Frequently asked Questions about Neuzumab 150mg Injection
-
Is this Neuzumab 150mg Injection habit forming or addictive?
Neuzumab 150mg Injection is not addictive in nature.
No -
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Neuzumab 150mg Injection can make you feel drowsy.
Dangerous -
Is it safe?
Yes, but consume Neuzumab 150mg Injection only on doctor's advice.
Safe, but take only on Doctor's advise -
Is it able to treat mental disorders?
Neuzumab 150mg Injection is unable to treat or cure mental disorders.
No
Neuzumab 150mg Injection Interactions with Food and Alcohol
-
Interaction between Food and Neuzumab 150mg Injection
It is safe to take Neuzumab 150mg Injection with food.
Safe -
Interaction between Alcohol and Neuzumab 150mg Injection
Due to lack of research, nothing can be said about side effects of consuming alcohol while taking Neuzumab 150mg Injection.
Unknown
See all substitutes for Neuzumab
- Herclon Injection - ₹46309
- Eleftha 440 Mg Injection - ₹18995
- Tarzed 440mg Injection - ₹61288
- Hermab 150mg Injection - ₹21440
- Hervycta 440mg Injection - ₹18900
- Hervycta Plus 150mg Injection - ₹22347
- Hervycta Plus 440mg Injection - ₹39496
- Vicentra 150mg Injection - ₹22800
- Vicentra 440mg Injection - ₹59970
- Hervycta 150mg Injection - ₹6500
- Trasmab 440mg Injection - ₹54650
- Trazumab 440mg Injection - ₹52866
- Priunta 440mg Injection - ₹54264
- Priunta 150mg Injection - ₹17990
- Ontramab 440mg Injection - ₹19800
- Ontramab 150mg Injection - ₹8900
- Neuzumab 440mg Injection - ₹19800
- Neuzumab 150mg Injection - ₹8900
- Herti 440mg Injection - ₹54266
- Hersima 440mg Injection - ₹54662
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Herceptin® (trastuzumab)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 114-116